ARDX

$3.030.00%0.00

Ardelyx Inc (ARDX)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$3.03

Offen:

$2.99

24-Stunden-Volumen:

4,612,220

Relatives Volumen:

1.18

Marktkapitalisierung:

$782.31M

Einnahmen:

$427.68M

Nettoeinkommen (Verlust:

-$58.06M

KGV:

EPS:

-$0.2382

Netto-Cashflow:

-$37.50M

1W Leistung:

+1.00%

1M Leistung:

-9.28%

6M Leistung:

-55.96%

1Y Leistung:

-48.82%

1-Tages-Spanne:

$0.00$0.00

1-Wochen-Bereich:

$2.96$3.16

52-Wochen-Spanne:

$2.96$8.40

Ardelyx Inc Aktie (ARDX) Unternehmensprofil

Firmenname

Ardelyx Inc

Sektor

Healthcare

Branche

Biotechnology

Telefon

510-745-7047

Adresse

34175 ARDENWOOD BLVD., FREMONT, CA, USA

Mitarbeiter

489

@ardelyx

Nächster Verdiensttermin

2026-11-03

Neueste SEC-Einreichungen

SEC

ARDX-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Ardelyx Inc Aktie (ARDX) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-06-16	Resumed	Ladenburg Thalmann	Buy
2026-01-09	Hochstufung	Piper Sandler	Neutral → Overweight
2025-09-03	Resumed	Raymond James	Strong Buy
2025-06-18	Resumed	H.C. Wainwright	Buy
2025-05-02	Herabstufung	Raymond James	Strong Buy → Outperform
2025-03-07	Resumed	Ladenburg Thalmann	Buy
2025-03-04	Eingeleitet	BTIG Research	Buy
2024-11-11	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-07-02	Herabstufung	Piper Sandler	Overweight → Neutral
2024-04-05	Eingeleitet	Leerink Partners	Outperform
2023-12-18	Eingeleitet	Raymond James	Strong Buy
2023-09-07	Eingeleitet	H.C. Wainwright	Buy
2023-08-25	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2023-03-03	Hochstufung	Wedbush	Neutral → Outperform
2022-11-17	Hochstufung	Piper Sandler	Neutral → Overweight
2022-05-06	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2021-12-01	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2021-10-14	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2021-07-21	Herabstufung	Jefferies	Buy → Hold
2021-07-20	Herabstufung	Piper Sandler	Overweight → Neutral
2021-07-20	Herabstufung	Wedbush	Outperform → Neutral
2021-03-23	Eingeleitet	Wedbush	Outperform
2021-01-06	Eingeleitet	Cantor Fitzgerald	Overweight
2020-10-20	Resumed	Citigroup	Buy
2020-02-18	Resumed	Jefferies	Buy
2020-02-12	Eingeleitet	Citigroup	Buy
2020-02-10	Eingeleitet	Cowen	Outperform
2019-04-08	Eingeleitet	Piper Jaffray	Overweight
2018-08-24	Eingeleitet	Jefferies	Buy
2018-03-19	Resumed	Leerink Partners	Outperform
2017-11-29	Bestätigt	Citigroup	Buy
2017-11-22	Bestätigt	Ladenburg Thalmann	Buy
2017-10-17	Resumed	Leerink Partners	Outperform
2016-03-31	Eingeleitet	Ladenburg Thalmann	Buy
2016-03-09	Eingeleitet	Cantor Fitzgerald	Buy
2016-03-03	Eingeleitet	Citigroup	Buy

Finanzdaten der Ardelyx Inc-Aktie (ARDX)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	407.32	333.62	124.46	52.16	10.10
Cost of revenue USD (M)	39.54	50.56	17.80	4.12	1.00
Gross profit USD (M)	-	-	106.66	48.04	9.10
Research and development USD (M)	71.53	52.32	35.54	35.20	91.14
Operating expenses USD (M)	448.30	311.01	169.94	111.80	163.44
Operating income USD (M)	-40.98	-27.95	-63.28	-63.76	-154.35
Income before tax USD (M)	-60.63	-38.87	-65.52	-67.20	-158.16
Income tax expense USD (M)	0.97	0.27	0.55	0.01	0.00
Net income USD (M)	-61.60	-39.14	-66.07	-67.21	-158.17
Basic EPS USD/shares	-0.26	-0.17	-0.30	-0.42	-1.52
Diluted EPS USD/shares	-0.26	-0.17	-0.30	-0.42	-1.52
Basic weighted shares shares (M)	241.03	235.23	219.33	158.69	104.21
Diluted weighted shares shares (M)	241.03	235.23	219.33	158.69	104.21
Selling, general and administrative USD (M)	337.23	258.69	134.40	-	-

Ardelyx Inc-Aktie (ARDX) Insiderhandel

Foster Eric DuaneAug 21 '26
Officer
Transaktion
Proposed Sale
Kosten
$4.03
#Aktien
11,900
Wert ($)
47,957
#Aktien Gesamt
0
Bishop John EAug 21 '26
Officer
Transaktion
Proposed Sale
Kosten
$4.03
#Aktien
25,500
Wert ($)
102,765
#Aktien Gesamt
0
Brady James ParkerAug 21 '26
Officer
Transaktion
Proposed Sale
Kosten
$4.03
#Aktien
19,700
Wert ($)
79,391
#Aktien Gesamt
0
Brady James ParkerAug 21 '26
Chief Human Resources Officer
Transaktion
Sale
Kosten
$3.86
#Aktien
15,136
Wert ($)
58,378
#Aktien Gesamt
245,930
Foster Eric DuaneAug 21 '26
Chief Commercial Officer
Transaktion
Sale
Kosten
$3.86
#Aktien
8,562
Wert ($)
33,023
#Aktien Gesamt
409,410
Kelliher MikeAug 21 '26
Chief Business Officer
Transaktion
Sale
Kosten
$3.86
#Aktien
7,758
Wert ($)
29,922
#Aktien Gesamt
349,660
Williams Laura AAug 21 '26
Chief Patient Officer
Transaktion
Sale
Kosten
$3.86
#Aktien
10,739
Wert ($)
41,419
#Aktien Gesamt
367,456
RAAB MICHAELAug 21 '26
President & CEO
Transaktion
Sale
Kosten
$3.86
#Aktien
58,574
Wert ($)
225,914
#Aktien Gesamt
1,619,792
Hohenleitner SusanAug 21 '26
Officer
Transaktion
Proposed Sale
Kosten
$4.03
#Aktien
2,650
Wert ($)
10,680
#Aktien Gesamt
0
Reilly Joseph JamesAug 21 '26
See Remarks
Transaktion
Sale
Kosten
$3.86
#Aktien
3,982
Wert ($)
15,358
#Aktien Gesamt
145,854

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Foster Eric Duane	Officer	Aug 21 '26	Proposed Sale	$4.03	11,900	47,957	0
Bishop John E	Officer	Aug 21 '26	Proposed Sale	$4.03	25,500	102,765	0
Brady James Parker	Officer	Aug 21 '26	Proposed Sale	$4.03	19,700	79,391	0
Brady James Parker	Chief Human Resources Officer	Aug 21 '26	Sale	$3.86	15,136	58,378	245,930
Foster Eric Duane	Chief Commercial Officer	Aug 21 '26	Sale	$3.86	8,562	33,023	409,410
Kelliher Mike	Chief Business Officer	Aug 21 '26	Sale	$3.86	7,758	29,922	349,660
Williams Laura A	Chief Patient Officer	Aug 21 '26	Sale	$3.86	10,739	41,419	367,456
RAAB MICHAEL	President & CEO	Aug 21 '26	Sale	$3.86	58,574	225,914	1,619,792
Hohenleitner Susan	Officer	Aug 21 '26	Proposed Sale	$4.03	2,650	10,680	0
Reilly Joseph James	See Remarks	Aug 21 '26	Sale	$3.86	3,982	15,358	145,854

Ardelyx Inc Aktie (ARDX) Neueste Nachrichten

Nov 02, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Nov 02, 2026

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky - GlobeNewswire

Nov 02, 2026

Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

Nov 02, 2026

Nov 01, 2026

Does Ardelyx (ARDX) Look Undervalued After New XPHOZAH Data? - Simply Wall St

Nov 01, 2026

Oct 31, 2026

HONA DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Honeywell Aerospace Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HONA - GlobeNewswire Inc.

Oct 31, 2026

Ardelyx Inc (41X.SG) Seasonal returns chart - Yahoo Finance Australia

Oct 31, 2026

ANAVEX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.

Oct 31, 2026

Ardelyx Deadline: ARDX Investors with Losses in Excess of $100K Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - herald-dispatch.com

Oct 31, 2026

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX - GlobeNewswire Inc.

Oct 31, 2026

Oct 30, 2026

Ardelyx: Revisiting The Thesis 2 Years On, I'm Surprised At Lack Of Progress (NASDAQ:ARDX) - Seeking Alpha

Oct 30, 2026

Ardelyx, Inc. (ARDX) Seasonal returns chart - Yahoo Finance Australia

Oct 30, 2026

Oct 29, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 29, 2026

Oct 28, 2026

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky - PR Newswire

Oct 28, 2026

Kaplan Fox Urges Ardelyx, Inc. (NASDAQ: ARDX) Investors to Contac - The National Law Review

Oct 28, 2026

Oct 27, 2026

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX - FinancialContent

Oct 27, 2026

Oct 26, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 26, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV

Oct 26, 2026

Oct 25, 2026

ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX - GlobeNewswire Inc.

Oct 25, 2026

ROSEN, REGARDED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.

Oct 25, 2026

Oct 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 22, 2026

ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt - Morningstar

Oct 22, 2026

Oct 21, 2026

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX - GlobeNewswire Inc.

Oct 21, 2026

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Oct 21, 2026

Ardelyx (ARDX) Faces Securities Class Action - STL.News

Oct 21, 2026

ARDX Investor Alert: Ardelyx, Inc. Securities Class Action Notice - Contact Levi & Korsinsky - PR Newswire

Oct 21, 2026

Oct 20, 2026

FinancialContent - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX - FinancialContent

Oct 20, 2026

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - The Daily Tribune News

Oct 20, 2026

Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Yahoo Finance

Oct 20, 2026

Oct 19, 2026

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - The Conway Daily Sun

Oct 19, 2026

Robbins LLP Urges ARDX Stockholders to Contact the Firm for Information About the Securities ... - Herald and News

Oct 19, 2026

Robbins LLP Urges ARDX Stockholders to Contact the Firm for Information About the Securities Class Action Against Ardelyx, Inc. - GlobeNewswire Inc.

Oct 19, 2026

Wedbush Cuts Price Target on Ardelyx to $8 From $9, Keeps Outperform Rating - Yahoo Finance

Oct 19, 2026

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Baidu, Inc. (BIDU), Ardelyx, Inc. (ARDX), and Better Home & Finance Holding Company (BETR) Announced by Holzer & Holzer, LLC - WBOC TV

Oct 19, 2026

Oct 17, 2026

Ardelyx Inc (41X.HM) stock price, news, quote and history - Yahoo Finance UK

Oct 17, 2026

Oct 16, 2026

Kaplan Fox Continues to Remind Ardelyx, Inc. (NASDAQ: ARDX) Inves - The National Law Review

Oct 16, 2026

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire Inc.

Oct 16, 2026

Ardelyx Inc (41X.HM) stock price, news, quote and history - Yahoo Finance UK

Oct 16, 2026

Oct 15, 2026

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 15, 2026

Ardelyx Files $520k Lobbying Report for Third Quarter - Legis1

Oct 15, 2026

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt - Morningstar

Oct 15, 2026

Oct 14, 2026

ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your Losses - Morningstar

Oct 14, 2026

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX - GlobeNewswire Inc.

Oct 14, 2026

ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline - Morningstar

Oct 14, 2026

Oct 12, 2026

Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C - Yahoo Finance

Oct 12, 2026

Oct 11, 2026

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.

Oct 11, 2026

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX - GlobeNewswire Inc.

Oct 11, 2026

Oct 09, 2026

New Strong Sell Stocks for October 9th - Zacks Investment Research

Oct 09, 2026

Oct 08, 2026

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX - GlobeNewswire Inc.

Oct 08, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 08, 2026

SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX - Morningstar

Oct 08, 2026

Ähnlich wie ARDX